Document is current
Any future updates will be listed below
-
Authors
Hærvig, Katia Keglberg https://orcid.org/0000-0002-4250-7948
Petersen, Kajsa Ugelvig
Giwercman, Aleksander
Hougaard, Karin Sørig
Høyer, Birgit Bjerre
Lindh, Christian
Ramlau-Hansen, Cecilia Høst
Nybo Andersen, Anne-Marie
Toft, Gunnar
Bonde, Jens Peter
Tøttenborg, Sandra Søgaard
-
Funding
Funding for this research was provided by:
Lundbeckfonden (R170-2014-855)
Interreg (20200407)
Axel Muusfeldts Fond (2016-491)
Læge Sophus Carl Emil Friis og hustru Olga Doris Friis' Legat
Fonden til Lægevidenskabens Fremme (16-37)
Region Hovedstaden (E-12205-01-04-01)
Dagmar Marshalls Fond (500020)
Helsefonden
- License Information
-
More Information
Article History
Received: 12 May 2021
Accepted: 4 April 2022
First Online: 27 April 2022
Declarations
:
: Aleksander Giwercman has received research grants from Ferring Pharmaceuticals and personal fees from Besins Healthcare Nordic and Sandoz, unrelated to the submitted work. The authors declare that they have no other conflicts of interest.
: Informed consent was obtained from all individual participants included in this study.
: Not applicable.
: This study was conducted in accordance with the Declaration of Helsinki. The establishment of the FEPOS cohort was approved by the Scientific Research Ethics Committee for Copenhagen and Frederiksberg (No. H-16015857) and the Knowledge Centre on Data Protection Compliance under the records of processing regarding health science research projects within the Capitol Region of Denmark (P-2019-503). Recruitment and data collection were also permitted by the Steering Committee of the DNBC (Ref. nos. 2016-08 and 2020-27).
